Category: St. Jude MedicalSyndicate content

St. Jude's Prodigy chronic pain neurostim device lands CE Mark

March 20, 2014 by Brad Perriello

St. Jude Medical says its Prodigy neurostimulation device won CE Mark approval in the European Union for a chronic pain indication.

St. Jude's Prodigy chronic pain Nuristan device lands CE Mark

St. Jude Medical (NYSE:STJ) said it's putting its Prodigy neurostimulation device on the market in Europe for patients with chronic back pain after winning CE Mark approval.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Volcano appeals loss to St. Jude Medical in FFR war

March 19, 2014 by Brad Perriello

Volcano appeals a Delaware federal judge's dismissal of its lawsuit against St. Jude Medical over fractional flow reserve patents.

Volcano appeals loss to St. Jude Medical in FFR war
Volcano appeals loss to St. Jude Medical in FFR war

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

St. Jude Medical launches post-approval Nanostim trial in Europe

March 18, 2014 by Brad Perriello

St. Jude Medical says it's launched a post-approval study in Europe for its Nanostim leadless pacemaker and performed the 1st implantations in a U.S. pivotal trial.

St. Jude Medical launches post-approval Nanostim trial in Europe

St. Jude Medical (NYSE:STJ) said it's enrolled the 1st patients in a post-approval trial of the Nanostim leadless pacemaker it acquired in October 2013.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Medtech trends: The most talked about device makers in February 2014

March 4, 2014 by Arezu Sarvestani

MassDevice.com looks at the internet chatter surrounding the medical device industry with some of most searched-for companies of the last month.

chart

Click to enlarge.

MassDevice.com looked at some of the most talked-about medical device companies, based on trends in U.S. Google searches for the last 30 days.

Volcano loses round in FFR war with St. Jude Medical

March 3, 2014 by Brad Perriello

Volcano agrees that St. Jude Medical isn't infringing a pair of its fractional flow reserve patents after a court ruling doesn't go its way, but vows to appeal.

Volcano loses round in FFR war with St. Jude Medical
Volcano loses round in FFR war with St. Jude Medical

J&J's Biosense Webster wins PMA nod from FDA for force-sensing catheter

February 25, 2014 by Brad Perriello

Johnson & Johnson's Biosense Webster subsidiary is the 1st to the U.S. market with a force-sensing ablation catheter for atrial fibrillation, the ThermoCool SmartTouch device.

J&J's Biosense Webster wins PMA nod from FDA for force-sensing catheter

Johnson & Johnson's (NYSE:JNJ) Biosense Webster subsidiary said it won pre-market approval from the FDA for its ThermoCool SmartTouch force-sensing ablation catheter, making it the 1st such device to hit the U.S. market.

Built on an AdaptiveTheme using Drupal by Michael Knapp  mknapp